BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)
Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –
BeOne Medicines market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BeOne Medicines's market cap was $47.47B on Nov 11, 2026, against $37.68B a year earlier. Over the last 5 years it ranged from $14.00B to $47.47B, with a median of $22.92B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $47.47B | +41.2% |
| 2025 | Dec 31, 2025 | $33.61B | +70.7% |
| 2024 | Dec 31, 2024 | $19.69B | +4.9% |
| 2023 | Dec 29, 2023 | $18.77B | -17.8% |
| 2022 | Dec 30, 2022 | $22.83B | -9.7% |
| 2021 | Dec 31, 2021 | $25.28B | +7.5% |
| 2020 | Dec 31, 2020 | $23.51B | +2250.8% |
| 2019 | Dec 31, 2019 | $1.00B | -88.0% |
| 2018 | Dec 31, 2018 | $8.32B | +87.7% |
| 2017 | Dec 29, 2017 | $4.43B | +343.0% |
| 2016 | Dec 30, 2016 | $1.00B | – |
See a number that looks wrong?